Please login to the form below

Not currently logged in
Email:
Password:

drug delivery

This page shows the latest drug delivery news and features for those working in and with pharma, biotech and healthcare.

Catalent preps for complex therapy boom with $1.2bn Paragon buy

Catalent preps for complex therapy boom with $1.2bn Paragon buy

The CDMO has a 25-year history in the production of gene therapies, including adeno-associated virus (AAV) vectors, the most commonly used delivery system, as well as plasmids and lentivirus ... and specialty drug discovery, oral drug delivery and

Latest news

More from news
Approximately 2 fully matching, plus 174 partially matching documents found.

Latest Intelligence

  • Launch trends 2019 Launch trends 2019

    What are the big trends in pharma and biotech drug launches for 2019? ... This requires a shift from a ‘drug company’ to a ‘care delivery’ mindset, and manufacturers should begin planning for the commercialisation considerations early in the

  • Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe

    Alnylam was also forced to abandon one of its first pipeline drugs, revusiran, after it was linked to deaths in trials, but persisted, developing a safer and more potent drug delivery ... platform. Led by founder and CEO John Maraganore, Alynlam finally

  • Digging deeper to connect with the powerful force of patient understanding Digging deeper to connect with the powerful force of patient understanding

    The global pharmaceutical industry spends more than 2bn on market research to provide insights that herald business advantages as well as improve drug delivery despite the current climate of challenging budgets. ... Of course, we need efficacy to have a

  • The true potential of mobile health tech The true potential of mobile health tech

    If it works, we will get better drug delivery, improved adherence, more committed patients and a reduction of waste.

  • How Augmented reality is disrupting healthcare How Augmented reality is disrupting healthcare

    2. Improve understanding of complex treatments. Unprecedented scientific discovery has led to an increased focus on developing specialised treatments that are highly complex - both in action and in delivery. ... Think of the value of virtually

More from intelligence
Approximately 0 fully matching, plus 25 partially matching documents found.

Latest appointments

  • Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO

    Edward Hæggström, CEO of Nanoform said: “Andrade’s background and experience in drug delivery will be a huge asset to the company. ... Tara Rheault. Rheault has more than 16 years of cross-functional leadership experience across drug discovery and

  • Concept Life Sciences adds to its scientific and commercial team Concept Life Sciences adds to its scientific and commercial team

    Dr Calvert has experience in the delivery of integrated drug discovery and development solutions, supporting organisations ranging from virtual companies to global pharma. ... He joins Concept from Aptuit, where he held various roles including senior

  • Philips promotes Simon McGuire to health systems lead Philips promotes Simon McGuire to health systems lead

    He was previously GM at Philips Respironics Respiratory Drug Delivery. Technology company Philips has appointed Simon McGuire as its health systems lead for the UK and Ireland, reporting directly to chief ... McGuire was previously Philips' general

  • Albumedix appoints Dr Giles Campion as CMO Albumedix appoints Dr Giles Campion as CMO

    Dr Campion will be responsible for the firm's global development efforts, with a particular focus on its albumin-based drug delivery platform. ... He brings over 25 years of drug development experience to the role, most recently as group vice president

  • Catalent appoints two board members Catalent appoints two board members

    Jack Stahl and Rolf Classon to advise drug development, delivery and supply company. ... Jack Stahl, former CEO of cosmetics firms Revlon, and Rolf Classon, former chairman at Bayer Healthcare, will use to their experience to advise Catalent, a leading

More from appointments
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest from PMHub

  • Patient Centricity: Turning Rhetoric into Reality

    However is this transformation working? A patient-centric model demands huge investment and a company-wide commitment to putting patient wants and needs first during all stages of healthcare delivery, from ... drug discovery through to long-term disease

  • Creative Medical Research

    Diabetes. Pulmonary. Anaesthesia. Surgical. Drug delivery. Patient warming. Diagnostics.and vascular access to name but a few. ... Infusion. Vascular access. Surgical consummables. Diagnostics and monitoring. Drug delivery. Specific therapy areas we've

  • Catalent

    From drug and biologic development services to delivery technologies to supply solutions, we are the catalyst for your success.

  • Catalent Pharma Solutions

    From drug and biologic development services to delivery technologies to supply solutions, we are the catalyst for your success.

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics